← Back to screener

WEST PHARMACEUTICAL SERVICES INC WST

Rank #1149 · NYSE · $29.2B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
53.0
P/E
49.1
P/B
10.86
ROE
22.1%
Op. Margin
22.9%
Debt Ratio
36%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 49.1x, P/B 10.86x. Ranks in the top 67% of the universe.

Profitability ★★★★☆
Excellent

ROE 22.1%. Ranks in the top 18% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 36%. Ranks in the top 19% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Average

Revenue growth of 2.2% year over year. Ranks in the top 58% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2010–$0.1B$0.1B$0.5B–141
2012–$0.1B$0.1B$0.6B–129
2013–$0.1B$0.1B$0.6B–133
2014–$0.1B$0.1B$0.7B–117
2015–$0.2B$0.1B$0.7B–98
2016–$0.2B$0.1B$0.9B–74
2017–$0.1B$0.1B$1.0B–63
2018$1.5B$0.2B$0.1B$1.0B12.957
2019$1.6B$0.2B$0.2B$1.1B14.152
2020$1.7B$0.2B$0.2B$1.3B14.060
2021$1.8B$0.3B$0.2B$1.4B16.167
2022$2.1B$0.4B$0.3B$1.6B19.062
2023$2.8B$0.8B$0.7B$1.9B26.650
2024$2.9B$0.7B$0.6B$2.3B25.441
2025$2.9B$0.7B$0.6B$2.7B22.936

← See the full screener